DCF — COVENANT MEDICAL CENTER
Enterprise Value: $-387.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-387.1M
Enterprise Value
$-129.5M
PV of Cash Flows
$-257.6M
PV of Terminal Value
$-414.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $450.8M | $-20.3M | -5.0% | $-39.4M | $-35.8M |
| Year 2 | $464.3M | $-16.3M | -4.0% | $-35.9M | $-29.7M |
| Year 3 | $478.3M | $-12.0M | -3.0% | $-32.2M | $-24.2M |
| Year 4 | $492.6M | $-9.9M | -2.0% | $-30.7M | $-21.0M |
| Year 5 | $507.4M | $-8.9M | -2.0% | $-30.4M | $-18.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-387.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$437.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000001028150366
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5